Degania Medical Devices Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.78 M
as on 15-11-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 17.13%
(FY 2023)
- Profit 67.51%
(FY 2023)
- Ebitda 72.91%
(FY 2023)
- Net Worth 24.91%
(FY 2023)
- Total Assets 31.26%
(FY 2023)
About Degania Medical Devices
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.78 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Bhardwaj, Mauricio Arellano, and David Lustig serve as directors at the Company.
- CIN/LLPIN
U74999HR2004PTC035786
- Company No.
035786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationGurgoan, Haryana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Degania Medical Devices Private Limited offer?
Degania Medical Devices Private Limited offers a wide range of products and services, including Cotton, Khadi, Other Fabric Clothing, Cotton Clothing, Catheter, Diagnostic Catheter, Central Venous Catheters, Baby Care Products, Feeding Bottles & Sippers, Surgical Accessories, Surgical Instruments, Introducer Sheath.
Who are the key members and board of directors at Degania Medical Devices?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Bhardwaj  | Managing Director | 24-Oct-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mauricio Arellano  | Director | 21-Apr-2022 | Current |
David Lustig  | Director | 26-Aug-2024 | Current |
Financial Performance of Degania Medical Devices.
Degania Medical Devices Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.13% increase. The company also saw a substantial improvement in profitability, with a 67.51% increase in profit. The company's net worth Soared by an impressive increase of 24.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Degania Medical Devices?
In 2023, Degania Medical Devices had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Degania Medical Devices?
Degania Medical Devices has a workforce of 543 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Degania Medical Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Degania Medical Devices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
